In infections with gram-negative bacteria, the unfavorable pro-inflammatory cytokine response cannot be decreased by an inhibitor targeting GrKs active site, as GrK induces the pro-inflammatory cytokine response by binding to LPS and transferring LPS to CD14. The gene discussed is GZMK; the disease is infection.